Follow the Gentian Diagnostics ASA share price and the full management transaction log of the company, a publicly traded company based in Norway. Shares trade on the NO market, under the supervision of Oslo Børs. Operating in the Health Care sector, Gentian Diagnostics ASA has published 23 insider filings. Market capitalisation: €573.5m. The latest transaction was disclosed on 29 May 2026 (Other). Among the most active insiders: Matti Heinonen. All data is openly available.
23
Insider Decl.
n/a
Thresholds
€703,164
6 ops.
Buy Volume
€5m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Gentian Diagnostics ASA Strong Buy (bullish), based on 1 analysts. Average price target: NOK 60.00.
18Σ signal
Buys €703,164€5m Sells
Fundamental score
Ranked 14,207 of 29,063 companies
52.6
score / 100
Value
47
Quality
59
FCF yld5.2%
Earn yld2.2%
EV/EBITDA17.9x
ROE-4.4%
Gross mgn56%
Net mgn7.5%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.